Novel knowledge on the alterations in immune response in patients with ATTR suggests a significant role of inflammation in ATTR progression that can add incremental value to the understanding of the natural history of subclinical cardiac amyloidosis [134]. The gene discussed is TTR; the disease is cardiac amyloidosis.